Cogent Biosciences (COGT) Enterprise Value (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Enterprise Value of -$866.4 million for Q1 2026, down 252.67% year-over-year from $567.5 million in Q1 2025, and up 3.82% quarter-over-quarter from -$900.8 million in Q4 2025.
Cogent Biosciences (COGT) Enterprise Value (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Enterprise Value for 10 consecutive years, with -$866.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 252.67% year-over-year to -$866.4 million; the TTM figure through Mar 2026 stood at -$866.4 million (down 252.67% YoY), while the FY2025 annual figure was -$900.8 million, down 213.77% from the prior year.
- Enterprise Value improved to -$866.4 million in Q1 2026 per COGT's latest filing, from -$900.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$141.1 million in Q4 2022 and bottomed at -$900.8 million in Q4 2025.
- Historically, Enterprise Value has averaged -$355.7 million across 5 years, with a median of -$289.1 million in 2022.
- Annual changes were most pronounced in 2025 — Enterprise Value jumped 43.62% — and 2026, when it sank 252.67%.
- Cogent Biosciences' Enterprise Value stood at -$141.1 million in 2022, then plunged by 88.26% to -$265.7 million in 2023, then retreated by 8.04% to -$287.1 million in 2024, then plunged by 213.77% to -$900.8 million in 2025, then gained by 3.82% to -$866.4 million in 2026.
- Business Quant data shows COGT's Enterprise Value at -$866.4 million in Q1 2026, -$900.8 million in Q4 2025, and -$390.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | -792.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -792.30 Mn |
| Mar 31, 2026 | -866.38 Mn |
| Dec 31, 2025 | -900.77 Mn |
| Sep 30, 2025 | -390.89 Mn |
| Jun 30, 2025 | -237.85 Mn |
| Mar 31, 2025 | -245.66 Mn |
| Dec 31, 2024 | -287.08 Mn |
| Sep 30, 2024 | -335.52 Mn |
| Jun 30, 2024 | -363.22 Mn |
| Mar 31, 2024 | -435.74 Mn |
| Dec 31, 2023 | -265.71 Mn |
| Sep 30, 2023 | -279.04 Mn |
| Jun 30, 2023 | -329.40 Mn |
| Mar 31, 2023 | -161.95 Mn |
| Dec 31, 2022 | -141.14 Mn |
| Sep 30, 2022 | -289.09 Mn |
| Jun 30, 2022 | -326.82 Mn |
| Mar 31, 2022 | -191.05 Mn |
| Dec 31, 2021 | -219.68 Mn |
| Sep 30, 2021 | -202.89 Mn |